NFE2L2 and lung adenocarcinoma: Similarly, in the classic KP model for lung adenocarcinoma driven by KrasG12D activation and p53 loss, moderate NRF2 activation promoted cancer initiation and early progression while strong NRF2 activation blocked progression to advanced cancer (26).